BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16773391)

  • 1. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies.
    Falagas ME; Apostolou KE; Pappas VD
    Eur J Clin Microbiol Infect Dis; 2006 Jul; 25(7):419-25. PubMed ID: 16773391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.
    Morgan J; Meltzer MI; Plikaytis BD; Sofair AN; Huie-White S; Wilcox S; Harrison LH; Seaberg EC; Hajjeh RA; Teutsch SM
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):540-7. PubMed ID: 16018429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attributable mortality of nosocomial candidemia, revisited.
    Gudlaugsson O; Gillespie S; Lee K; Vande Berg J; Hu J; Messer S; Herwaldt L; Pfaller M; Diekema D
    Clin Infect Dis; 2003 Nov; 37(9):1172-7. PubMed ID: 14557960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nosocomial candidemia on outcomes of critically ill patients.
    Blot SI; Vandewoude KH; Hoste EA; Colardyn FA
    Am J Med; 2002 Oct; 113(6):480-5. PubMed ID: 12427497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.
    Zaoutis TE; Argon J; Chu J; Berlin JA; Walsh TJ; Feudtner C
    Clin Infect Dis; 2005 Nov; 41(9):1232-9. PubMed ID: 16206095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species.
    Cheng MF; Yang YL; Yao TJ; Lin CY; Liu JS; Tang RB; Yu KW; Fan YH; Hsieh KS; Ho M; Lo HJ
    BMC Infect Dis; 2005 Apr; 5():22. PubMed ID: 15813977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs.
    Moran C; Grussemeyer CA; Spalding JR; Benjamin DK; Reed SD
    Pediatr Infect Dis J; 2009 May; 28(5):433-5. PubMed ID: 19319021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-onset candidemia at a university hospital, 1995-2005.
    Kung HC; Wang JL; Chang SC; Wang JT; Sun HY; Hsueh PR; Chen YC
    J Microbiol Immunol Infect; 2007 Aug; 40(4):355-63. PubMed ID: 17712471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of candidemia in intensive care units.
    Bouza E; Muñoz P
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S87-91. PubMed ID: 19013346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
    Yamamura DL; Rotstein C; Nicolle LE; Ioannou S
    CMAJ; 1999 Feb; 160(4):493-9. PubMed ID: 10081465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of independent risk factors for death among pediatric patients with candidemia and a central venous catheter in place.
    Pasqualotto AC; de Moraes AB; Zanini RR; Severo LC
    Infect Control Hosp Epidemiol; 2007 Jul; 28(7):799-804. PubMed ID: 17564981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
    Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
    Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess mortality, length of stay and cost attributable to candidaemia.
    Hassan I; Powell G; Sidhu M; Hart WM; Denning DW
    J Infect; 2009 Nov; 59(5):360-5. PubMed ID: 19744519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of adverse outcome from candidal infection in a tertiary care hospital.
    Ben-Abraham R; Keller N; Teodorovitch N; Barzilai A; Harel R; Barzilay Z; Paret G
    J Infect; 2004 Nov; 49(4):317-23. PubMed ID: 15474630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality.
    Alonso-Valle H; Acha O; García-Palomo JD; Fariñas-Alvarez C; Fernández-Mazarrasa C; Fariñas MC
    Eur J Clin Microbiol Infect Dis; 2003 Apr; 22(4):254-7. PubMed ID: 12709840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.
    Al-Tawfiq JA
    Int J Infect Dis; 2007 May; 11(3):239-44. PubMed ID: 16859945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
    Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
    Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidemia in Intensive Care patients. Risk factors and mortality.
    Piazza O; Boccia MC; Iasiello A; Storti MP; Tufano R; Triassi M
    Minerva Anestesiol; 2004; 70(1-2):63-9. PubMed ID: 14765046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Candidemia in an intensive care unit].
    Adukauskiene D; Kinderyte A; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(5):351-6. PubMed ID: 19535880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia.
    Uzun O; Ascioglu S; Anaissie EJ; Rex JH
    Clin Infect Dis; 2001 Jun; 32(12):1713-7. PubMed ID: 11360213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.